Stansberry Asset Management’s Biogen BIIB Stock Holding History

Stansberry Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,663	Closed	-$3.54M	–	53
2021 Q1	$3.54M	Buy	12,663 +87	+0.7%	+$23.5K	0.94%	36
2020 Q4	$3.08M	Buy	12,576 +632	+5%	+$163K	0.86%	34
2020 Q3	$3.39M	Buy	+11,944	New	+$3.33M	1.16%	28
2018 Q1	–	Sell	-8,212	Closed	-$2.62M	–	74
2017 Q4	$2.62M	Buy	+8,212	New	+$2.63M	1.13%	29

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Stansberry Asset Management's BIIB Position: Q2 2021 in Review

Stansberry Asset Management sold out of Biogen (BIIB) in Q2 2021, closing a stake of 12,663 shares — an estimated $3.54M sold.

Stansberry Asset Management first reported a position in BIIB in Q4 2017 and held it in 4 quarters. The position peaked at $3.54M in Q1 2021. 1,104 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

Stansberry Asset Management reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
Stansberry Asset Management sold 12,663 Biogen shares in Q2 2021, an estimated $3.54M.
Stansberry Asset Management first reported a position in Biogen in Q4 2017 and held it in 4 quarters.
Stansberry Asset Management's Biogen position peaked at $3.54M in Q1 2021.
1,104 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Stansberry Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.